Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

NCT07232654 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

LOCALLY ADVANCED CERVICAL CANCERS

Interventions

DRUG: Iparomlimab/Tuvonralimab
DRUG: Cisplatin
RADIATION: Brachytherapy and External Beam Radiotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences